Luís Brieva

Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis.

Mar Tintoré, Àlex Rovira, María Jesús Martinez et al. · PubMed · 2000 · 428 citations · Full text

Cerebellar Ataxia With Anti–Glutamic Acid Decarboxylase Antibodies

Jérôme Honnorat, Albert Saiz, Bruno Giometto et al. · Archives of Neurology · 2001 · 378 citations

Isolated demyelinating syndromes: comparison of CSF oligoclonal bands and different MR imaging criteria to predict conversion to CDMS

Mar Tintoré, A. Rovira, Luís Brieva et al. · Multiple Sclerosis Journal · 2001 · 111 citations

A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis

Xavier Montalbán, Jaume Sastre‐Garriga, Mar Tintoré et al. · Multiple Sclerosis Journal · 2009 · 108 citations

Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial

John Foley, Gilles Defer, Lana Zhovtis Ryerson et al. · The Lancet Neurology · 2022 · 103 citations

Relapsing-remitting Multiple Sclerosis, Clinical Neurology, Clinical Trials +8